Investment
Features
FeesSafety
Academy
More
Pluang+

Flex fintech doubles valuation to $1.2B after $60M Series B funding led by Portage Ventures

Market News
14 Jul 2026
Crypto Briefing
View Source
Bullish
Flex fintech doubles valuation to $1.2B after $60M Series B funding led by Portage Ventures

Flex, a San Francisco-based AI fintech startup targeting mid-sized US businesses, has doubled its valuation to $1.2 billion following a $60 million Series B funding round led by Portage Ventures. The company integrates payments, private credit, and finance tools into one AI-driven platform and has seen a 4x revenue increase and tripled private credit offerings in the past year. This growth highlights strong institutional demand for alternative lending beyond traditional banks. With $105 million in equity and a $200 million credit facility, Flex is well-positioned to expand its services and compete with crypto lending platforms targeting similar markets.

More News

Acoramidis shows 18% lower risk of death and hospitalizations versus tafamidis in real-world ATTR-CM study

Acoramidis shows 18% lower risk of death and hospitalizations versus tafamidis in real-world ATTR-CM study

Acoramidis, a drug for transthyretin amyloid cardiomyopathy (ATTR-CM), was linked to an 18% lower risk of death, hospitalization, and disease progression compared to tafamidis in a large U.S. electronic health record study of 2,684 patients. The stud...

Market News
Bullish
1 hour ago
Stellantis unveils six bold concept cars ahead of the Paris Motor Show, showcasing future mobility and design innovation.

Stellantis unveils six bold concept cars ahead of the Paris Motor Show, showcasing future mobility and design innovation.

Stellantis revealed six concept cars from its iconic brands at an exclusive event before the Paris Motor Show, highlighting its FaSTLAne 2030 strategy focused on innovation, customer experience, and diverse mobility solutions. These concepts, includi...

Market News
Bullish
2 hours ago
New version of Freenome's blood test shows improved detection of advanced precancerous colorectal lesions

New version of Freenome's blood test shows improved detection of advanced precancerous colorectal lesions

Freenome announced improved clinical validation results for its updated SimpleScreen™ CRC blood test, showing an 18.2% sensitivity for advanced precancerous lesions (APLs), up from 13.7% in the original test. Sensitivity for high-grade dysplasia APLs...

Market News
Bullish
2 hours ago
Encaleret boosts bone turnover and improves symptoms in ADH1 patients, with FDA Priority Review underway.

Encaleret boosts bone turnover and improves symptoms in ADH1 patients, with FDA Priority Review underway.

BridgeBio Pharma announced that encaleret, a treatment for autosomal dominant hypocalcemia type 1 (ADH1), increased bone turnover and improved patient-reported symptoms in the Phase 3 CALIBRATE trial. 100% of patients on encaleret reported symptom im...

Company Fundamentals
Bullish
4 hours ago
iShares MSCI Europe Financials ETF upgraded to buy on low valuation and strong technical support after 11% drop

iShares MSCI Europe Financials ETF upgraded to buy on low valuation and strong technical support after 11% drop

Mike Zaccardi upgraded the iShares MSCI Europe Financials ETF (EUFN) to a buy rating, highlighting its attractive valuation at 8.8 times earnings and a PEG ratio below 1.0 due to an 11% recent price drop. Despite risks from Eurozone fiscal issues, th...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App